- Home
- VGZ vs FATE Comparison
VGZ vs FATE Comparison
Compare VGZ & FATE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- VGZ
- FATE
- Stock Information
- Founded
- VGZ 1983
- FATE 2007
- Country
- VGZ United States
- FATE United States
- Employees
- VGZ N/A
- FATE N/A
- Industry
- VGZ
- FATE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- VGZ
- FATE Health Care
- Exchange
- VGZ Nasdaq
- FATE Nasdaq
- Market Cap
- VGZ 127.3M
- FATE 129.5M
- IPO Year
- VGZ N/A
- FATE 2013
- Fundamental
- Price
- VGZ $0.94
- FATE $1.30
- Analyst Decision
- VGZ Strong Buy
- FATE Hold
- Analyst Count
- VGZ 1
- FATE 7
- Target Price
- VGZ $3.00
- FATE $3.83
- AVG Volume (30 Days)
- VGZ 412.2K
- FATE 1.5M
- Earning Date
- VGZ 08-08-2025
- FATE 08-12-2025
- Dividend Yield
- VGZ N/A
- FATE N/A
- EPS Growth
- VGZ N/A
- FATE N/A
- EPS
- VGZ 0.08
- FATE N/A
- Revenue
- VGZ N/A
- FATE $13,335,000.00
- Revenue This Year
- VGZ N/A
- FATE N/A
- Revenue Next Year
- VGZ N/A
- FATE N/A
- P/E Ratio
- VGZ $11.99
- FATE N/A
- Revenue Growth
- VGZ N/A
- FATE 105.85
- 52 Week Low
- VGZ $0.47
- FATE $0.66
- 52 Week High
- VGZ $1.30
- FATE $5.75
- Technical
- Relative Strength Index (RSI)
- VGZ 40.36
- FATE 60.32
- Support Level
- VGZ $0.92
- FATE $1.19
- Resistance Level
- VGZ $1.03
- FATE $1.19
- Average True Range (ATR)
- VGZ 0.03
- FATE 0.06
- MACD
- VGZ -0.00
- FATE 0.02
- Stochastic Oscillator
- VGZ 16.36
- FATE 80.16
About VGZ Vista Gold Corp
Vista Gold Corp is a gold mining company. It is engaged in the evaluation, acquisition, exploration, and advancement of gold exploration and potential development projects. The company evaluate, acquire, explore and advance gold exploration and potential development projects for gold production or value adding strategic transactions. The Company has one reportable segment: Australia. The Australia segment conducts exploration, development, care and maintenance activities at Vista's asset, the Mt Todd gold project in Northern Territory, Australia.
About FATE Fate Therapeutics Inc.
Fate Therapeutics Inc is a clinical-stage biopharmaceutical company based in the United States. It is engaged in the development of programmed cellular immunotherapies for cancer and autoimmune disorders. The company's cell therapy pipeline is comprised of NK- and T-cell immuno-oncology programs, including off-the-shelf engineered product candidates derived from clonal master iPSC lines, and immuno-regulatory programs, including product candidates to prevent life-threatening complications in patients.